<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24-vaccines-08-00307">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fahimi</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Mohammadipour</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Haddad Kashani</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Parvini</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Sadeghizadeh</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Dengue viruses and promising envelope protein domain III-based vaccines</article-title>
  <source>Appl. Microbiol. Biotechnol.</source>
  <year>2018</year>
  <volume>102</volume>
  <fpage>2977</fpage>
  <lpage>2996</lpage>
  <pub-id pub-id-type="doi">10.1007/s00253-018-8822-y</pub-id>
  <?supplied-pmid 29470620?>
  <pub-id pub-id-type="pmid">29470620</pub-id>
 </element-citation>
</ref>
